Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger-Reference-Cited by-同舟云学术

Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger

Published:2024-06-04 Issue:21 Volume:331 Page:1809
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Maurer Mathew S.¹,Miller Edward J.²,Ruberg Frederick L.³⁴

Affiliation:

1. Cardiac Amyloidosis Program, Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, and NewYork-Presbyterian Hospital, New York

2. Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut

3. Section of Cardiovascular Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts

4. Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2818879/jama_maurer_2024_ed_240018_1716910728.0345.pdf

Reference15 articles.

1. Cardiac amyloidosis due to transthyretin protein: a review.;Ruberg;JAMA,2024

2. Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic/Latino ancestry.;Damrauer;JAMA,2019

3. Association of transthyretin Val122Ile variant with incident heart failure among Black individuals.;Parcha;JAMA,2022

4. The amyloidogenic V122I transthyretin variant in elderly Black Americans.;Quarta;N Engl J Med,2015

5. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: distinct from wild-type transthyretin amyloidosis?;Razvi;Eur J Heart Fail,2024